妊娠中の肝臓酵素濃度の出生体重への影響
Qingxiu Li1,2, Mian Pan2,3, Jiayi Chen1,2
1Department of Epidemiology and Health Statistics, School of Public Health, Fujian Medical University, Fuzhou, 350004, China.
Maternal and child health journal
|September 5, 2025
まとめ
ガンマグルタミルトランスファーゼ (GGT) を含む妊娠中の母親の肝臓酵素レベルは,異常な出生体重と関連しています. これらの酵素とその変化のモニタリングは,マクロソミアや低出生体重 (LBW) などの不良胎児発達の予防に役立ちます.
科学分野:
- 産婦人科
- 妊婦と胎児の医療
- 生物化学
背景:
- 妊娠中の母親の健康は胎児の発達と出産に大きく影響します
- 肝臓酵素は 母親の代謝状態の重要な指標です
- 母親の肝臓酵素濃度と異常な出生体重の関係については,さらなる調査が必要である.
研究 の 目的:
- 妊娠中の母親の肝臓酵素濃度 (GGT,ALT,AST) と異常出生体重のリスクとの関連を調べる.
- 妊娠中の肝臓酵素濃度の変化が胎児の成長パラメータに影響するかどうかを判断する.
主な方法:
- 19,003人のシングルトン妊娠を対象とした前向きな出生コホート研究.
- 母親のガンマグルタミルトランスフェラーゼ (GGT),アラニンアミノトランスフェラーゼ (ALT),アスパルテートアミノトランスフェラーゼ (AST) を第1期と第3期で測定する.
- 出生体重,妊娠年齢に対して小さい (SGA),妊娠年齢に対して大きい (LGA),出生体重が低い (LBW),およびマクロソミアの分析.
主要な成果:
- 最初の3ヶ月間のGGTは,マクロソミアとLBWのリスクと正の相関関係があり,それぞれ妊娠糖尿病 (GDM) と妊娠年齢によって媒介されています.
- 肝臓酵素レベルは,LBWとSGAとの線形的な関係を示した.
- 妊娠中の肝臓酵素の変化は出生体重,LGA,マクロソミアと負の相関があり,SGAリスクと正の相関があった.
結論:
- 妊娠中の母親の肝臓酵素濃度とその変化は,胎児の出生体重に異なった程度の影響を与える.
- 妊娠中の母親の肝臓酵素のモニタリングは胎児の異常な発達を特定し,予防するのに役立ちます.
- これらの発見は,出産前ケアにおける肝臓酵素監視の重要性を強調しています. 出産の結果を最適化するために.
関連する概念動画
Teratogenicity
2.7K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.7K
Factors Affecting Drug Biotransformation: Biological
230
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
230
Liver Physiology
1.1K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
1.1K
Hepatic Drug Excretion: Influencing Factors
214
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
214
Factors Affecting Drug Response: Overview
2.3K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.3K
Hepatic Drug Clearance: Effect of Protein Binding
284
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
284


